CN111821266B - 一种牛磺酸缓释组合物及其制备方法 - Google Patents
一种牛磺酸缓释组合物及其制备方法 Download PDFInfo
- Publication number
- CN111821266B CN111821266B CN202010690058.9A CN202010690058A CN111821266B CN 111821266 B CN111821266 B CN 111821266B CN 202010690058 A CN202010690058 A CN 202010690058A CN 111821266 B CN111821266 B CN 111821266B
- Authority
- CN
- China
- Prior art keywords
- taurine
- release
- sustained
- drug
- slow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010690058.9A CN111821266B (zh) | 2020-07-17 | 2020-07-17 | 一种牛磺酸缓释组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010690058.9A CN111821266B (zh) | 2020-07-17 | 2020-07-17 | 一种牛磺酸缓释组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111821266A CN111821266A (zh) | 2020-10-27 |
CN111821266B true CN111821266B (zh) | 2021-09-14 |
Family
ID=72924396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010690058.9A Active CN111821266B (zh) | 2020-07-17 | 2020-07-17 | 一种牛磺酸缓释组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111821266B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115606730A (zh) * | 2022-10-13 | 2023-01-17 | 糖零生物科技(杭州)有限公司 | 一种添加赤藓糖醇的甜味饮料及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06002316A (es) * | 2003-09-03 | 2006-05-19 | Boehringer Ingelheim Int | Capsula que contiene granulos de sustancia activa con diferentes perfiles de liberacion. |
CN101288659B (zh) * | 2007-04-18 | 2014-06-18 | 王雷波 | 一种胃内漂浮型微丸及其制备方法 |
CN101987081B (zh) * | 2010-07-16 | 2012-08-08 | 钟术光 | 一种控释制剂 |
CN102058563B (zh) * | 2010-11-17 | 2013-04-24 | 桂林华信制药有限公司 | 一种双控释格列齐特缓释胶囊及其制备方法 |
CN102772392B (zh) * | 2012-08-21 | 2014-09-24 | 人福医药集团股份公司 | 一种阿比多尔缓控释胶囊及其制备方法 |
US20180214382A1 (en) * | 2015-07-07 | 2018-08-02 | Perora Gmbh | Edible composition comprising a polysaccharide and a lipid |
CN105434358A (zh) * | 2016-01-04 | 2016-03-30 | 河北工业大学 | 含牛磺酸的药物组合物及其应用 |
JP2020525549A (ja) * | 2017-06-27 | 2020-08-27 | ハーモニクス エルエルシー | 徐放性睡眠補助薬系 |
-
2020
- 2020-07-17 CN CN202010690058.9A patent/CN111821266B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111821266A (zh) | 2020-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2072840C1 (ru) | Твердая лекарственная форма пролонгированного действия для лечения сердечно-сосудистых заболеваний | |
CN103006612B (zh) | 一种赖诺普利迟释缓释片剂及其制备方法 | |
CN104013592A (zh) | 盐酸美金刚缓释药丸及其制备方法 | |
CN106420629B (zh) | 支链氨基酸制剂及其制备方法和应用 | |
CN108042503B (zh) | 一种高效的炎琥宁肠溶片及制备方法 | |
CN111821266B (zh) | 一种牛磺酸缓释组合物及其制备方法 | |
HRP20010706A2 (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
CN109010361B (zh) | 碳酸钙维生素d3制剂及其制备方法 | |
CN107982241B (zh) | 一种炎琥宁肠溶制剂及制备方法 | |
CN106963736A (zh) | 氢溴酸右美沙芬缓释干混悬剂及其制备方法 | |
CN110075082A (zh) | 一种恩诺沙星速释微丸及其制备方法 | |
CN113842447A (zh) | 一种降尿酸、缓解痛风的组合物及其制备方法 | |
CN106822907B (zh) | 一种含消旋卡多曲的双相释放制剂及其制备方法 | |
CN102755310B (zh) | 一种含有左旋多巴的组合物药物制剂 | |
CN105496967B (zh) | 盐酸雷尼替丁控释干混悬剂及其制备方法 | |
CN103230381B (zh) | 酒石酸唑吡坦择时脉冲控释微丸及其制备方法 | |
CN101224210A (zh) | 一种咪唑斯汀缓释胶囊 | |
CN102058878A (zh) | 一种胃内生成大蒜辣素的前体微丸片及其制备方法 | |
JP2002540153A (ja) | L−カルニチンまたはアルカノイルl−カルニチン高含有顆粒剤 | |
CN101130066A (zh) | 一种动物皮胶原蛋白多肽的结肠靶向制剂及其制备方法 | |
CN1631395A (zh) | 银杏叶缓释制剂及其制备方法 | |
CN103945832B (zh) | 用于脑能量分子延迟释放和持续释放的组合物,装置及方法 | |
CN1234361C (zh) | 左旋千金藤啶碱的新药物制备方法 | |
CN111821275A (zh) | 一种氟骨三醇控释片 | |
JPS63154619A (ja) | 頻尿および残尿感治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210810 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Applicant after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Applicant before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Dijia Pharmaceutical Group Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Taurine sustained release composition and preparation method thereof Effective date of registration: 20211025 Granted publication date: 20210914 Pledgee: Bank of China Limited Weihai Branch Pledgor: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2021980010533 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |